-
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Brokerages
来源: Buzz FX / 26 1月 2025 02:25:17 America/New_York
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat January 26, 2025 Share Link copied to clipboard. Sarepta Therapeutics, Inc. ( NASDAQ:SRPT - Get Free Report ) has ear
Read more...